FDA Hearing to Focus on All-Metal Hip Implants, Risk Prevention

The FDA will hold a two-day hearing to determine strategies to help physicians monitor the risks associated with all-metal hip replacements, according to a New York Times report.

Advertisement

In recent years, the medical device industry has come under intense scrutiny for the failure of several all-metal hip implants, which have led to complications, repeat surgeries and numerous lawsuits.

According to the report, a number of factors led to the widespread use and implantation of this type of device, including lack of FDA regulation on clinical trials, lack of data and knowledge on the risks related to the devices as well as lack of an orthopedic registry to assess outcomes following the implantations.

The hearing will start today where experts will be faced with difficult questions surrounding the lack of data and clinical trials for all-metal hip implants.

More Articles on Orthopedic Implants:

Greatbatch Medical Opens Manufacturing Center in Indiana
Collagen Matrix Celebrates 15-Year Anniversary
Joint Replacement Registries Struggle With Data Collection

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.